NLTX · Categories · 10-Q

NLTX - SEC Form 10-Q quarterly reports

Neoleukin Therapeutics Inc. (NLTX) sec form 10-q quarterly reports - real-time wire coverage filtered to 10-Q only.

Recent 10-Q for NLTX

• 1035d
  SEC Form 10-Q filed by Neoleukin Therapeutics Inc.

  10-Q - Neoleukin Therapeutics, Inc. (0001404644) (Filer)
• 1129d
  SEC Form 10-Q filed by Neoleukin Therapeutics Inc.

  10-Q - Neoleukin Therapeutics, Inc. (0001404644) (Filer)
• 1304d
  SEC Form 10-Q filed by Neoleukin Therapeutics Inc.

  10-Q - Neoleukin Therapeutics, Inc. (0001404644) (Filer)
• 1493d
  SEC Form 10-Q filed by Neoleukin Therapeutics Inc.

  10-Q - Neoleukin Therapeutics, Inc. (0001404644) (Filer)
• 1679d
  SEC Form 10-Q filed by Neoleukin Therapeutics, Inc.

  10-Q - Neoleukin Therapeutics, Inc. (0001404644) (Filer)
• 1770d
  SEC Form 10-Q filed by Neoleukin Therapeutics, Inc.

  10-Q - Neoleukin Therapeutics, Inc. (0001404644) (Filer)
• 1856d
  SEC Form 10-Q filed by Neoleukin Therapeutics, Inc.

  10-Q - Neoleukin Therapeutics, Inc. (0001404644) (Filer)

Other NLTX categories

• 8-K
• 10-K
• S-1
• 13D
• 13G
• Form 4
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends